US20100196079A1 - Dispensing Package - Google Patents

Dispensing Package Download PDF

Info

Publication number
US20100196079A1
US20100196079A1 US12/364,233 US36423309A US2010196079A1 US 20100196079 A1 US20100196079 A1 US 20100196079A1 US 36423309 A US36423309 A US 36423309A US 2010196079 A1 US2010196079 A1 US 2010196079A1
Authority
US
United States
Prior art keywords
dispensing package
section
elevator
antiperspirant composition
antiperspirant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/364,233
Other languages
English (en)
Inventor
Michael John Bolander
Joseph Estill Lennon
Songtao Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to US12/364,233 priority Critical patent/US20100196079A1/en
Assigned to THE PROCTER & GAMBLE COMPANY reassignment THE PROCTER & GAMBLE COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOLANDER, MICHAEL JOHN, LENNON, JOSEPH ESTILL, ZHOU, SONGTAO
Priority to MX2011008152A priority patent/MX2011008152A/es
Priority to CA2750102A priority patent/CA2750102C/en
Priority to BRPI1008067-8A priority patent/BRPI1008067B1/pt
Priority to PCT/US2010/022854 priority patent/WO2010088652A2/en
Priority to MX2014007471A priority patent/MX347967B/es
Priority to EP10703743.4A priority patent/EP2391239B1/en
Publication of US20100196079A1 publication Critical patent/US20100196079A1/en
Priority to US13/652,085 priority patent/US9795205B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D40/00—Casings or accessories specially adapted for storing or handling solid or pasty toiletry or cosmetic substances, e.g. shaving soaps or lipsticks
    • A45D40/02—Casings wherein movement of the lipstick or like solid is a sliding movement
    • A45D40/04—Casings wherein movement of the lipstick or like solid is a sliding movement effected by a screw

Definitions

  • the present invention is directed to dispensing packages that are used to apply cream or soft solid type antiperspirant and deodorant compositions to the underarm.
  • the present invention is also directed to antiperspirant products comprising a dispensing package and an antiperspirant composition containing a high efficacy antiperspirant active.
  • Swivel-up dispensing packages are typically employed for dispensing and applying cream antiperspirant compositions.
  • Known swivel-up dispensing packages include a composition chamber, an applicator surface, a turn wheel that drives a feed screw, and an elevator threadably engaged with the feed screw, which applies pressure to the composition as it is advanced towards the applicator surface.
  • Weeping onto the applicator surface following a not mal dispensing and application event can however be an undesirable side effect of this type of dispensing package.
  • Residual pressure within the composition remaining in the package chamber can cause the composition to weep onto the applicator surface for a period of time.
  • U.S. Pat. No. 5,000,356 discloses a solution to weeping.
  • the '356 patent teaches a packaging system that intermittently retracts the elevator a suitable distance following the dispensing of a discrete amount of the antiperspirant composition so that the residual pressure is relieved, thereby limiting or eliminating the weeping issue
  • One of the embodiments disclosed in the '356 patent utilizes a turn wheel with an integrally formed spring that flexes to permit axial displacement of the feed screw and engaged elevator during dispensing.
  • the spring utilizing its potential energy, retracts the feed screw and elevator away from the applicator surface to relieve the residual pressure within the volume of un-dispensed composition.
  • the Procter & Gamble Company has manufactured dispensing packages in accordance with the foregoing approach for a number of years.
  • the commercial packages utilized a one-piece turn wheel and feed screw made from an acetal resin. This is also the material disclosed in the '356 patent in connection with the above-described embodiment.
  • the flexural modulus of acetal is sufficient to provide the retraction necessary to substantially prevent weeping.
  • Employing acetal to manufacture a one-piece turn wheel and feed screw is acceptable for typical antiperspirant actives, but unfortunately, acetal can be susceptible to acid degradation when certain high efficacy actives are used in the antiperspirant composition.
  • the high efficacy actives can produce a significant amount of hydrochloric acid (HCl) in the presence of water/moisture, and this acid can, in turn, degrade the screw to the point of inoperativeness.
  • HCl hydrochloric acid
  • the '356 patent discloses the use of polypropylene in connection with alternative embodiments. Polypropylene is sufficiently resistant to HCL such that it would be suitable for manufacturing the feed screw. However, in a one-piece design where the turn wheel and feed screw are manufactured from the same resin, the polypropylene would be unacceptable since it possesses too low of a flexural modulus to retract the feed screw and elevator sufficiently to relieve the internal pressure necessary to sufficiently limit or prevent weeping.
  • the present invention provides dispensing package designs that are capable of both dispensing antiperspirant compositions containing high efficacy actives and limiting or eliminating weeping.
  • a dispensing package comprising: (a) a container body comprising an interior chamber to contain an antiperspirant composition and an applicator surface; (b) an elevator including a cross section that is congruent to and mounted for axial movement within the chamber; and (c) an actuator system operatively connected to the elevator for advancing the elevator within the chamber to dispense a portion of the antiperspirant composition, the actuator system comprising a first section that flexes towards the applicator surface during advancement of the elevator and then rebounds away from the applicator surface to retract the elevator after the advancement, and a second section that is exposed to the antiperspirant composition.
  • the first section is made from a polymer having a flexural modulus of from about 275 ksi to about 500 ksi and the second section is resistant to degradation by acide that can arise from a contained antiperspirant composition comprising an antiperspirant active having a metal to chloride ratio of less than or equal to 1.3.
  • FIG. 1 is a cross-sectional view of an exemplary dispensing package embodiment provided by the present invention
  • FIG. 2 is a partial perspective view of an exemplary actuator system employable in dispensing packages of the present invention
  • FIG. 3 is a partial side view of the exemplary actuator system shown in FIG. 2 , wherein a section of the actuator system is in a flexed state that occurs during dispensing;
  • FIG. 4 is a partial side view of the exemplary actuator system shown in FIGS. 2 and 3 , wherein the flexed section has returned to an un-flexed state.
  • an exemplary dispensing package 10 that includes a container body 12 , a portion of which defines a chamber 14 for holding an antiperspirant composition, an applicator surface 15 having a plurality of through holes 16 , an elevator 17 , and an exemplary actuator system 18 for advancing the elevator towards applicator surface 15 .
  • elevator 17 is shown in its upward most position. When chamber 14 contains a volume of an antiperspirant composition, elevator 17 will be located in a lower position than that shown in the figure.
  • the base 13 of container body 12 includes an arcuate section 20 that has a centrally located axially tapered hole 22 therein. Hole 22 is centered between a plurality of cantilevered fingers 24 . Each of fingers 24 has one end affixed to the container body base 13 and extends upwardly towards applicator surface 16 and radially inwardly towards the central axis, terminating in a free end. The free ends of fingers 24 are disposed at an elevation above base 13 and define the circumference of the tope of hole 22 . Each finger 24 is separated from adjacent fingers by slots, allowing each finger 24 to deflect independently.
  • Fingers 24 having fixed ends disposed about the circumference of hole 22 and which form an angle of about 70° relative to the horizontal are suitable. It will be apparent to one skilled in the art that fingers 24 can also be cantilevered from other positions of base 13 so long as they do not interfere with the movement of elevator 17 . It will be further apparent that fingers 24 could be oriented at other angles, including parallel to the horizontal.
  • each finger 24 Disposed on the free end of each finger 24 is a plurality of cams 26 which may be shaped like saw tooth ratchet teeth, v-shaped, or any other profile judged to be advantageous by the skilled artisan.
  • cams 26 have a forward face 27 ramped from about 20° to about 50°, preferably about 40° relative to the horizontal and an abrupt secondary face 28 .
  • the free end of fingers 24 will generally accommodate several cams 26 .
  • a space or land may be interposed between adjacent cams 26 to provide for a desired number of cams 26 on a finger 24 at a specified diameter and having a specified forward face 27 ramp angle.
  • exemplary actuator system 18 comprises fingers 24 and cams 26 .
  • Actuator system 18 further comprises an actuator defined by a turn wheel (interchangeably referred to as item 30 ) and feed screw 32 .
  • a turn wheel (interchangeably referred to as item 30 ) and feed screw 32 .
  • feed screw 32 Disposed about the periphery of feed screw 32 is a plurality of ratchet teeth or followers 34 adapted to engage cams 26 disposed on the free ends of fingers 24 .
  • Actuator or turn wheel 30 comprises a triskelion-shaped return spring 36 .
  • return spring 36 can be incorporated into turn wheel 30 is to provide a plurality of spokes 37 extending from a central portion of turn wheel 30 to the periphery of turn wheel 30 and radiating in a spiral pattern as shown.
  • the spokes 37 flex, allowing relative axial displacement between feed screw 32 and turn wheel 30 .
  • the spiral pattern of the spokes should be such that the spokes are tensioned as turn wheel 30 is rotated.
  • the return spring may be external to turn wheel 30 , such as, for example, a leaf spring cantilevered from the interior of container body 12 .
  • Dispensing packages of the present invention are designed for containing and dispensing cream or soft solid type antiperspirant compositions.
  • the compositions generally include a carrier, a structurant/thickener, an antiperspirant active, and one or more optional ingredients, such as, for example, perfume materials, emollients, moisturizes, and residue-masking agents.
  • Carrier materials can include, for example, a volatile silicone carrier whose concentration may be from about 20% or from about 30% but no more than about 80% or no more than about 60%, by weight of the composition.
  • the volatile silicone may be cyclic, linear, and/or branched chain silicone. “Volatile silicone”, as used herein, refers to those silicone materials that have measurable vapor pressure under ambient conditions.
  • volatile silicones are described in Todd et al., “Volatile Silicone Fluids for Cosmetics”, Cosmetics and Toiletries, 91:27-32 (1976).
  • the volatile silicone may be a cyclic silicone having from at least about 3 silicone atoms or from at least about 5 silicone atoms but no more than about 7 silicone atoms or no more than about 6 silicone atoms.
  • volatile silicones may be used which conforms to the formula:
  • n is from about 3 or from about 5 but no more than about 7 or no more than about 6.
  • volatile cyclic silicones generally have a viscosity of less than about 10 centistokes at 25° C.
  • Suitable volatile silicones for use herein include, but are not limited to, Cyclomethicone D5 (commercially available from G. E. Silicones); Dow Corning 344, and Dow Corning 345 (commercially available from Dow Corning Corp.); and GE 7207, GE 7158 and Silicone Fluids SF-1202 and SF-1173 (available from General Electric Co.).
  • SWS-033) 4 SWS-03400, F-222, F-223, F-250. F-251 (available from SWS Silicones Corp.); Volatile Silicones 7158, 7207, 7349 (available from Union Carbide); Masil SF-V (available from Mazer) and combinations thereof.
  • Suitable carrier materials can also include non-volatile organic fluids and non-volatile silicone fluids.
  • nonvolatile organic fluids include, but are not limited to, mineral oil, PPG-14 butyl ether, isopropyl myristate, petrolatum, butyl stearate, cetyl octanoate, butyl myristate, myristyl myristate, C12-15 alkylbenzoate, dipropylene glycol dibenzoate, PPG-15 stearyl ether benzoate and blends thereof, neopentyl glycol diheptanoate (e.g.
  • Lexfeel 7 supplied by Inolex octyldodecanol, isostearyl isostearate, octododecyl benzoate, isostearyl lactate, isostearyl palmitate, isononyl/isononoate, isoeicosane, octyldodecyl neopentanate, hydrogenated polyisobutane, and isobutyl stearate.
  • Representative nonvolatile silicone fluids include those which conform to the formula:
  • n is greater than or equal to 1.
  • linear silicone materials may generally have viscosity values of from about 5 centistokes, from about 10 centistokes but no more than about 100,000 centistokes, no more than about 500 centistokes, no more than about 200 centistokes or no more than about 50 centistokes, as measured under ambient conditions.
  • suitable nonvolatile silicone fluids include Dow Corning 200, hexamethyldisiloxane, Dow Corning 225, Dow Corning 1732, Dow Corning 5732, Dow Corning 5750 (available from Dow Corning Corp,); and SF-96. SF-1066 and SF18(350) Silicone Fluids (available from G.E. Silicones).
  • the antiperspirant compositions also comprise structuring/thickening agents to help provide the composition with the desired viscosity, rheology, texture and/or product hardness, or to otherwise help suspend any dispersed solids or liquids within the composition.
  • the term “thickening agent” may include any material known or otherwise effective in providing suspending, gelling, viscosifying, solidifying or thickening properties to the composition or which otherwise provide structure to the final product form.
  • These thickening agents may include gelling agents, polymeric or nonpolymeric agents, inorganic thickening agents, or viscosifying agents.
  • the thickening agents may include organic solids, silicone solids, crystalline or other gellants, inorganic particulates such as clays or silicas, or combinations thereof.
  • the concentration and type of the thickening agent selected for use in the antiperspirant composition of the present invention will vary depending upon the desired product form, viscosity, and hardness.
  • the thickening agents may, for example, have a concentration range from at least about 0.1%, at least about 3%, or at least about 5% but no more than about 35%, no more than about 20%, or no more than about 10%, by weight of the composition.
  • Non-limiting examples of suitable gelling agents of the present invention include fatty acid gellants, salts of fatty acids, hydroxyl acids, hydroxyl acid gellants, esters and amides of fatty acid or hydroxyl fatty acid gellants, cholesterolic materials, dibenzylidene alditols, lanolinolic materials, fatty alcohols, triglycerides, sucrose esters such as SEFA behenate, inorganic materials such as clays or silicas, other amide or polyamide gellants, and mixtures thereof.
  • the antiperspirant compositions of the present invention include any particulate antiperspirant active suitable for application to human skin.
  • concentration of antiperspirant active in the composition should be sufficient to provide the finished antiperspirant product with the desired perspiration wetness and odor control.
  • the compositions of the present invention mat contain particulate antiperspirant materials at concentrations ranging from about 0.1% to about 28% antiperspirant active by weight of the compositions, preferably from about 2% to about 22%, and more preferably from about 15% to about 20%. These weight percentages are calculated on an anhydrous unbuffered basis (exclusive of glycine, the salts of glycine, or other complexing agents).
  • the particulate antiperspirant materials preferably have particle sizes of less than about 125 microns.
  • the antiperspirant active used herein has a metal to chloride molar ratio of less than or equal to about 1.3.
  • Exemplary metal to chloride molar ratios include from about 1.3 to about 0.9, and from about 1.15 to about 1.3.
  • Particulate antiperspirant materials suitable for use herein are those that include any compound, composition or mixture thereof having antiperspirant activity.
  • Astringent metallic salts are preferred antiperspirant materials for use herein, particularly the inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof.
  • Particularly preferred are the aluminum and zirconium salts, such as aluminum halides, aluminum hydroxy halides, zirconyl oxide halides, zirconyl hydroxy halides, and mixtures thereof.
  • Preferred aluminum salts are those represented by the formula:
  • a is from about 0 to about 4.5; the sum of a and b is about 6; x is from about 1 to about 8; and wherein a, b, and x may have non-integer values.
  • Particularly preferred are the aluminum chlorhydroxides referred to as “3 ⁇ 4 basic chlorhydroxide,” wherein a is about 4.5, “2 ⁇ 3 basic chlorhydroxide,” wherein a is about 4, and aluminum chloride wherein a is about 0.
  • Processes for preparing aluminum salts are disclosed in U.S. Pat. No. 3,887,692, Gilman, issued Jun. 3, 1975; U.S. Pat. No. 3,904,741, Jones et al., issued Sep. 9, 1975; U.S. Pat. No.
  • Zirconium salts are also preferred for use in the antiperspirant compositions. These salts are represented by the formula:
  • zirconium salts are described in Belgian Patent 825,146, Schmitz, issued Aug. 4, 1975.
  • Particularly preferred zirconium salts are those complexes that additionally contain aluminum and glycine, commonly known as ZAG complexes.
  • ZAG complexes contain aluminum chlorhydroxide and zirconyl hydroxy chloride of the formulae described above.
  • Preferred ZAG salts are described in U.S. Pat. No. 4,331,609, Orr, issued May 25, 1982.
  • Other such ZAG complexes are described in U.S. Pat. No. 3,679,068.
  • Polymer size distribution of the antiperspirant actives of the compositions of the present invention can be defined by the size exclusion chromatography method as described hereinafter using Gel Permeation Chromatography (GPC).
  • Solid antiperspirant active salts are dissolved in 0.01M nitric acid and chromatographed using 5 ⁇ l injections in a series of three consecutive Waters ⁇ Porasil Columns, 3.9 ⁇ 300 mm, 10 ⁇ m packing. A 0.01M nitric acid mobile phase is employed. Chromatograms arc visualized using a Waters 410 Differential Refractometer. Samples are prepared immediately prior to analysis to prevent degradation. Relative peak areas and area ratios are calculated using a Waters Millennium Data System (Version 2.10 or equivalent).
  • Peaks I-II The peaks observed in the chromatogram are designated in order of appearance on the chromatogram as Peaks I-II (appear as a single peak) and Peaks III, IV and V.
  • the area of Peaks III, IV and V corresponds to the relative concentration of aluminum polymer species exiting the column during the specified time period from the injected sample.
  • the area of Peaks I-II corresponds to the relative concentration of co-eluting aluminum and zirconium polymer species appearing initially on the chromatogram.
  • the columns Prior to any analysis, the columns should be conditioned individually by repeated 100 ⁇ l injections of a 10% zirconium-aluminum tetrachlorohydrate glycine solution (containing at least 10% zirconium on a solid basis).
  • Antiperspirant actives of the compositions of the present invention can have an average Peak IV area as defined by the methodology herein of at least about 7%, preferably at least about 20%, and more preferably at least about 25%.
  • Exemplary antiperspirant actives for use in the compositions of the present invention include aluminum chloride, aluminum dichlorohydrate, aluminum sesquichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium tetrachlorohydrate glycine, aluminum zirconium octachlorohydrate glycine, and mixtures thereof.
  • Antiperspirant actives having a metal to chloride ratio of less than or equal to 1.3 are preferred due to their relatively high efficacy towards providing wetness protection. Such actives can however lead to the generation of a significant level of hydrochloric acid in the final composition when the composition is exposed to moisture (e.g., when the product stored in a high humidity environment such as a bathroom). The hydrochloric acid can degrade certain polymers associated with the dispensing package, ultimately to a point of inoperatability.
  • dispensing packages that are suitable for delivering antiperspirant compositions employing actives with a metal to chloride ratio of less than or equal to 1.3 preferably utilize polymer resins that are resistant to attack from the HCl, at least for the packaging components that are in contact with the antiperspirant composition.
  • Polymer resin selection for packaging components that, as discussed above, provide sufficient flexural properties is also important for dispensing packages that rely on the flexural properties to intermittently retract the elevator and feed screw to relieve the internal pressure from the antiperspirant composition to prevent/inhibit weeping. Accordingly, there are two factors that must be considered when selecting appropriate polymer resins for dispensing packages of the present invention.
  • An acid degradation test was employed to evaluate various resins and their suitability for use in packaging components that come into contact with antiperspirant compositions having actives with a metal to chloride ratio of less than or equal to 1.3.
  • the test can be conducted as follows: weigh resin samples or plastic part samples made from the resin, dispense 5 ml (or other appropriate volumes for varying sample sizes) of 1M HCl into a vial, drop the samples into the vial, put the vials into a 85° C. oven for 19 hours, pull the vials from the oven and allow to cool, rinse the samples and dry the same, and then re-weigh the samples to determine weight loss as an indicator of whether or not there was acid degradation.
  • a flexural modulus in the range of about 275 ksi to about 500 ksi has been found to be suitable for providing sufficient flexural properties to intermittently retract the elevator and feed screw to relieve the internal pressure from the antiperspirant composition to prevent/inhibit weeping.
  • Polymer resins having a flexural modulus significantly below 275 ksi e.g., Polypropylene at 214 ksi
  • the flexural modulus values shown in Table 1 below are those reported by the resin supplier. Flexural modulus is typically determined by either ASTM D790 or ISO 178 test methods.
  • exemplary actuator system 18 includes a feed screw 32 that is exposed to the contained antiperspirant composition, and accordingly must be sufficiently resistant to degradation from any generated HCl.
  • exemplary actuator system 18 also includes an actuator in the form of a turn wheel 30 that provides the spring force (via the integral triskelion-shaped spring) to retract the feed screw 32 and elevator 17 sufficiently to inhibit/eliminate weeping.
  • two different polymer resins can be employed for the feed screw and the actuator so that the degradation and flexural modulus design criteria can be considered.
  • the feed screw can be made from a material such as polypropylene and the turn wheel made from a material such as acetal.
  • Different manufacturing techniques can be utilized with this design approach.
  • the feed screw and turn wheel can be independently manufactured and then subsequently assembled.
  • dual injection molding techniques can be employed to mold the separate parts out of different resins.
  • one or more rotatable molds can be employed for the molding and assembly steps.
  • U.S. Pat. Nos. 6,783,346; 7,081,222; and 7,320,591 disclose exemplary rotatable molding and in-mold assembly techniques.
  • a single polymer resin is chosen to mold both the feed screw and the actuator, wherein the chosen resin is both resistant to acid degradation and has a flexural modulus between about 275 ksi and 500 ksi.

Landscapes

  • Cosmetics (AREA)
US12/364,233 2009-02-02 2009-02-02 Dispensing Package Abandoned US20100196079A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US12/364,233 US20100196079A1 (en) 2009-02-02 2009-02-02 Dispensing Package
MX2011008152A MX2011008152A (es) 2009-02-02 2010-02-02 Envase dispensador.
CA2750102A CA2750102C (en) 2009-02-02 2010-02-02 Dispensing package
BRPI1008067-8A BRPI1008067B1 (pt) 2009-02-02 2010-02-02 Produto antiperspirante
PCT/US2010/022854 WO2010088652A2 (en) 2009-02-02 2010-02-02 Dispensing package
MX2014007471A MX347967B (es) 2009-02-02 2010-02-02 Envase dispensador.
EP10703743.4A EP2391239B1 (en) 2009-02-02 2010-02-02 Dispensing package
US13/652,085 US9795205B2 (en) 2009-02-02 2012-10-15 Dispensing package

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/364,233 US20100196079A1 (en) 2009-02-02 2009-02-02 Dispensing Package

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/652,085 Continuation US9795205B2 (en) 2009-02-02 2012-10-15 Dispensing package

Publications (1)

Publication Number Publication Date
US20100196079A1 true US20100196079A1 (en) 2010-08-05

Family

ID=42108865

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/364,233 Abandoned US20100196079A1 (en) 2009-02-02 2009-02-02 Dispensing Package
US13/652,085 Active 2031-06-15 US9795205B2 (en) 2009-02-02 2012-10-15 Dispensing package

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/652,085 Active 2031-06-15 US9795205B2 (en) 2009-02-02 2012-10-15 Dispensing package

Country Status (6)

Country Link
US (2) US20100196079A1 (es)
EP (1) EP2391239B1 (es)
BR (1) BRPI1008067B1 (es)
CA (1) CA2750102C (es)
MX (2) MX347967B (es)
WO (1) WO2010088652A2 (es)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD732976S1 (en) 2014-09-17 2015-06-30 The Procter & Gamble Company Applicator dome
US20150201735A1 (en) * 2014-01-21 2015-07-23 The Procter & Gamble Company Packaged Antiperspirant Compositions
US9795206B2 (en) 2014-12-22 2017-10-24 The Procter & Gamble Company Package for consumer care products
US9820551B2 (en) 2014-12-22 2017-11-21 The Procter & Gamble Company Package for consumer care products
US9867445B2 (en) 2014-12-22 2018-01-16 The Procter & Gamble Company Package for consumer care products
USD810568S1 (en) 2016-06-10 2018-02-20 The Procter & Gamble Company Applicator dome
US20180086541A1 (en) * 2016-09-23 2018-03-29 The Procter & Gamble Company Consumer Product Package
US20180125199A1 (en) * 2016-11-09 2018-05-10 Lombardi Design & Mfg. Liquid make-up stick and method of manufacturing and using the same
US10315832B2 (en) 2016-09-23 2019-06-11 The Procter & Gamble Company Consumer product package
US10517373B2 (en) 2014-12-22 2019-12-31 The Procter & Gamble Company Package for consumer care products
US11685590B2 (en) 2016-12-27 2023-06-27 Doselogix, Llc Dosing dispenser system
US11938507B2 (en) * 2014-10-15 2024-03-26 Doselogix, Llc Metering dispenser for flowable compositions

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120168439A1 (en) 2011-01-05 2012-07-05 Steven Francis Quigley Wet friction material for closures for product containers
WO2017117111A1 (en) * 2015-12-27 2017-07-06 Plastek Industries, Inc. Pressure-relief personal care applicator
US11382400B2 (en) 2018-08-10 2022-07-12 Go Products Co. Material applicator
BR112023002420A2 (pt) 2020-09-01 2023-03-21 Procter & Gamble Embalagem dispensadora e método para liberação controlada de uma composição viscosa

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547302A (en) * 1994-07-29 1996-08-20 The Procter & Gamble Company Twist-up product dispenser having conformable apertured applicator surface

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679068A (en) 1970-08-17 1972-07-25 Pullman Inc Cushioning arrangement for railway car
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
DE2504381A1 (de) 1974-02-04 1975-12-18 Procter & Gamble Zirkonium- und hafniumsalze und ihre komplexe mit aluminiumverbindungen und aminosaeuren, verfahren zur herstellung dieser salze und komplexe sowie antiperspirationsmittel, die diese komplexe enthalten
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
US4120948A (en) 1976-11-29 1978-10-17 The Procter & Gamble Company Two phase antiperspirant compositions
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4331609A (en) 1980-09-08 1982-05-25 The Procter & Gamble Company Antiperspirant composition
GB2144992A (en) 1983-08-16 1985-03-20 Gillette Co Antiperspirants
US5000356A (en) 1987-10-15 1991-03-19 The Procter & Gamble Company Swivel-up type dispensing package
EP1027199A1 (en) 1997-02-25 2000-08-16 Jes Tougaard Gram Procedure and machine for multi component moulding
US5947621A (en) * 1997-02-26 1999-09-07 The Plastek Group Cosmetic dispenser for gels and cremes including method of assembling and loading the dispenser
US6357945B1 (en) * 1998-01-21 2002-03-19 Colgate Palmolive Company Cosmetic dispenser
US5961007A (en) * 1998-06-15 1999-10-05 The Procter & Gamble Company Dispensing package
EP1349719B1 (en) 2000-10-26 2010-10-06 GRAM, Jes Tougaard Procedure for the molding and assembling of an assembled object
EP1226916A1 (de) 2001-01-29 2002-07-31 FOBOHA GmbH Vorrichtung und Verfahren zur Herstellung von Objekten aus Kunststoff

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547302A (en) * 1994-07-29 1996-08-20 The Procter & Gamble Company Twist-up product dispenser having conformable apertured applicator surface

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150201735A1 (en) * 2014-01-21 2015-07-23 The Procter & Gamble Company Packaged Antiperspirant Compositions
US9872551B2 (en) * 2014-01-21 2018-01-23 The Procter & Gamble Company Packaged antiperspirant compositions
USD758881S1 (en) 2014-09-17 2016-06-14 The Procter & Gamble Company Applicator dome
USD732976S1 (en) 2014-09-17 2015-06-30 The Procter & Gamble Company Applicator dome
US11938507B2 (en) * 2014-10-15 2024-03-26 Doselogix, Llc Metering dispenser for flowable compositions
US10517373B2 (en) 2014-12-22 2019-12-31 The Procter & Gamble Company Package for consumer care products
US9795206B2 (en) 2014-12-22 2017-10-24 The Procter & Gamble Company Package for consumer care products
US9820551B2 (en) 2014-12-22 2017-11-21 The Procter & Gamble Company Package for consumer care products
US9867445B2 (en) 2014-12-22 2018-01-16 The Procter & Gamble Company Package for consumer care products
USD810568S1 (en) 2016-06-10 2018-02-20 The Procter & Gamble Company Applicator dome
USD886636S1 (en) 2016-06-10 2020-06-09 The Procter & Gamble Company Applicator dome
US20180086541A1 (en) * 2016-09-23 2018-03-29 The Procter & Gamble Company Consumer Product Package
US10625927B2 (en) 2016-09-23 2020-04-21 The Procter & Gamble Company Consumer product package
US10315832B2 (en) 2016-09-23 2019-06-11 The Procter & Gamble Company Consumer product package
US20180125199A1 (en) * 2016-11-09 2018-05-10 Lombardi Design & Mfg. Liquid make-up stick and method of manufacturing and using the same
US11685590B2 (en) 2016-12-27 2023-06-27 Doselogix, Llc Dosing dispenser system
US11731827B1 (en) 2016-12-27 2023-08-22 Doselogix, Llc Dosing dispenser system

Also Published As

Publication number Publication date
EP2391239A2 (en) 2011-12-07
CA2750102A1 (en) 2010-08-05
EP2391239B1 (en) 2015-07-29
MX2011008152A (es) 2011-08-17
MX347967B (es) 2017-05-18
WO2010088652A3 (en) 2010-10-21
BRPI1008067A2 (pt) 2017-10-17
US20130039687A1 (en) 2013-02-14
BRPI1008067B1 (pt) 2020-02-11
WO2010088652A2 (en) 2010-08-05
CA2750102C (en) 2018-01-16
US9795205B2 (en) 2017-10-24

Similar Documents

Publication Publication Date Title
US9795205B2 (en) Dispensing package
EP2649900B1 (en) Process for the manufacture of a deodorant and/or antiperspirant product
US6783027B2 (en) Metered-dose underarm product and package
US11491099B2 (en) Antiperspirant and deodorant compositions
US20050287069A1 (en) Method of determining performance of an antiperspirant compositions
US20130108570A1 (en) Antiperspirant Soft Solid Compositions Comprising A Wax Blend
US6719965B2 (en) Antiperspirant or deodorant composition
US9565919B2 (en) Antiperspirant compositions and methods for making same
US10576308B2 (en) Antiperspirant products
EP3041458B1 (en) Antiperspirant compositions comprising hydroxyalkyl urea
WO2014088586A1 (en) Antiperspirant/deodorant cosmetic compositions

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE PROCTER & GAMBLE COMPANY, OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BOLANDER, MICHAEL JOHN;LENNON, JOSEPH ESTILL;ZHOU, SONGTAO;REEL/FRAME:023533/0831

Effective date: 20090918

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION